Loading resource…

Hospital Clínico Universitario de Valencia, Universitat de Valencia, CIBER Cardiovascular, Hospital Universitario Ramón y Cajal, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Germans Trias i Pujol Health Science
This review examines the utility of CA 125 as a biomarker for heart failure, focusing on its ability to quantify congestion and inflammation, which are key factors in disease progression and acute decompensation. The document details how CA 125 levels correlate with right-sided heart failure parameters and adverse clinical events, offering prognostic value beyond traditional markers like natriuretic peptides. It also discusses the emerging role of CA 125 in guiding treatment strategies, including adjustments to diuretic therapy and risk stratification during follow-up after hospital discharge.
No account needed